Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012

S W Patrick, M M Davis, C U Lehmann, W O Cooper, S W Patrick, M M Davis, C U Lehmann, W O Cooper

Abstract

Objective: Neonatal abstinence syndrome (NAS), a postnatal opioid withdrawal syndrome, increased threefold from 2000 to 2009. Since 2009, opioid pain reliever prescriptions and complications increased markedly throughout the United States. Understanding recent changes in NAS and its geographic variability would inform state and local governments in targeting public health responses.

Study design: We utilized diagnostic and demographic data for hospital discharges from 2009 to 2012 from the Kids' Inpatient Database and the Nationwide Inpatient Sample. NAS-associated diagnoses were identified utilizing International Classification of Diseases, Ninth Revision, Clinical Modification codes. All analyses were conducted with nationally weighted data. Expenditure data were adjusted to 2012 US dollars. Between-year differences were determined utilizing least squares regression.

Results: From 2009 to 2012, NAS incidence increased nationally from 3.4 (95% confidence interval (CI): 3.2 to 3.6) to 5.8 (95% CI 5.5 to 6.1) per 1000 hospital births, reaching a total of 21,732 infants with the diagnosis. Aggregate hospital charges for NAS increased from $732 million to $1.5 billion (P<0.001), with 81% attributed to state Medicaid programs in 2012. NAS incidence varied by geographic census division, with the highest incidence rate (per 1000 hospital births) of 16.2 (95% CI 12.4 to 18.9) in the East South Central Division (Kentucky, Tennessee, Mississippi and Alabama) and the lowest in West South Central Division Oklahoma, Texas, Arkansas and Louisiana 2.6 (95% CI 2.3 to 2.9).

Conclusion: NAS incidence and hospital charges grew substantially during our study period. This costly public health problem merits a public health approach to alleviate harm to women and children. States, particularly, in areas of the country most affected by the syndrome must continue to pursue primary prevention strategies to limit the effects of opioid pain reliever misuse.

Conflict of interest statement

Conflict of Interest Disclosures: No disclosures or potential conflicts of interest to report.

Figures

Figure 1. Incidence of neonatal abstinence syndrome…
Figure 1. Incidence of neonatal abstinence syndrome per 1,000 hospital births in the United States, 2009-2012
* Data obtained from the Kids’ Inpatient Database for 2009 and 2012 and from the Nationwide Inpatient Sample in 2010 at 2011. ** 2009: 3.4 (95%CI 3.2-3.6); 2010: 4.8 (95%CI 4.3-5.2); 2011: 5.0 (95%CI 4.4-5.4); 2012: 5.8 (95%CI 5.5-6.1)
Figure 2. Incidence of neonatal abstinence syndrome…
Figure 2. Incidence of neonatal abstinence syndrome per 1,000 hospital births by US Census Bureau geographic division, 2012
Figure 2. Incidence of neonatal abstinence syndrome…
Figure 2. Incidence of neonatal abstinence syndrome per 1,000 hospital births by US Census Bureau geographic division, 2012

References

    1. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–60.
    1. Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol. 2011;204(3):259 e1-4.
    1. Finnegan LP, Kron RE, Connaughton JF, E JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm. 1975;12(1-2):19–32.
    1. Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US Children’s Hospitals, 2004-2011. J Perinatol. 2014
    1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934–40.
    1. Vital Signs: Overdoses of Prescription Opioid Pain Relievers — United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487–81.
    1. Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol. 2013;23(8):498–503.
    1. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002.
    1. Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):563–8.
    1. Centers for Disease Control and Prevention. Prescription Drug Overdose in the United States: Fact Sheet. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Available from: .
    1. HCUP Kids’ Inpatient Database. Healthcare Cost and Utilization Project (HCUP) Rockville, MD: Agency for Healthcare Research and Quality; 2000, 2003, 2006, 2009, 2012. Available from: .
    1. HCUP Nationwide Inpatient Sample. Healthcare Cost and Utilization Project (HCUP) Rockville, MD: Agency for Healthcare Research and Quality; 2009-2011. Available from: .
    1. Patrick SW, Davis MM, Sedman AB, Meddings JA, Hieber S, Lee GM, et al. Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns. Pediatrics. 2013;131(Suppl 1):S75–80.
    1. Auger KA, Patrick SW, Davis MM. Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents. Pediatrics. 2013;132(5):e1149–55.
    1. Afana M, Brinjikji W, Cloft H, Salka S. Hospitalization Costs for Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention in the United States Are Substantially Higher Than Medicare Payments. Clinical cardiology. 2014
    1. Kozhimannil KB, Arcaya MC, Subramanian SV. Maternal Clinical Diagnoses and Hospital Variation in the Risk of Cesarean Delivery: Analyses of a National US Hospital Discharge Database. PLoS medicine. 2014;11(10):e1001745.
    1. International Classification of Diseases, 9th Revision - Clinical Modification. American Medical Association; Chicago, IL: 2012. p. 360.
    1. US Bureau of Labor Statistics. [2014 July 15];Consumer Price Index. 2014 Available from:
    1. Pisati M. Simple thematic mapping. The Stata Journal. 2004;4:361–78.
    1. National Oceanic and Atmospheric Administration. US States and Territories Silver Spring, MD: 2014. Available from: .
    1. Eapen V, Dadds M, Barnett B, Kohlhoff J, Khan F, Radom N, et al. Separation anxiety, attachment and inter-personal representations: disentangling the role of oxytocin in the perinatal period. PLoS One. 2014;9(9):e107745.
    1. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006;26(1):15–7.
    1. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134(2):e527–34.
    1. Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123(5):e849–56.
    1. Jansson LM. ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman. Breastfeed Med. 2009;4(4):225–8.
    1. Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA. 2013;309(17):1821–7.
    1. Jansson LM, Velez M, Harrow C. Methadone maintenance and lactation: a review of the literature and current management guidelines. J Hum Lact. 2004;20(1):62–71.
    1. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian family physician Medecin de famille canadien. 2007;53(10):1722–30.
    1. Hunseler C, Bruckle M, Roth B, Kribs A. Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr. 2013;225(5):247–51.
    1. Saiki T, Lee S, Hannam S, Greenough A. Neonatal abstinence syndrome--postnatal ward versus neonatal unit management. Eur J Pediatr. 2010;169(1):95–8.
    1. ACOG Committee on Health Care for Underserved Women American Society of Addiction Medicine. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and gynecology (New York 1953) 2012;119(5):1070–6.
    1. Fullerton CA, Kim M, Thomas CP, Lyman DR, Montejano LB, Dougherty RH, et al. Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv. 2014;65(2):146–57.
    1. TennCare. [2014 October 27];Neonatal Abstinence Syndrome among TennCare enrollees Provisional 2012 data Nashville. TN2013. Available from: .
    1. PDMP Assist. [2014 June 18];PDMP Program Status 2014. Available from: .
    1. Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care. 2012;50(6):494–500.
    1. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev. 2007;26(5):487–92.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner